Scarica l'app Stockscreener
1.23
1.65%
0.02
Dopo l'orario di chiusura:
1.23
Nrx Pharmaceuticals Inc Borsa (NRXP) Ultime notizie
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Po - GuruFocus.com
Earnings call: NRx Pharmaceuticals projects profitability by 2025 - Investing.com Canada
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2024 Earnings Call Transcript - Insider Monkey
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer - BioSpace
NRx Pharmaceuticals Reports Progress in Drug Development - TipRanks
NRx Pharmaceuticals names Michael Abrams as new CFO - Investing.com
NRx Pharmaceuticals Names Biotech Veteran Michael Abrams as New CFO to Drive Growth | NRXP Stock News - StockTitan
NRXPNRX Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
NRX Pharmaceuticals Inc (NRXP) Quarterly 10-Q Report - Quartzy
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update - Yahoo Finance
NRx Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
NRx Pharmaceuticals delays Q3 results call to November 18 By Investing.com - Investing.com Canada
NRx Pharmaceuticals delays Q3 results call to November 18 - Investing.com
NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024 - XM
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024 - Yahoo Finance
NRx Pharmaceuticals (NRXP) Scheduled to Post Earnings on Thursday - Defense World
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024 - BioSpace
NRx Pharmaceuticals Sets Q3 2024 Earnings Call for November 14 | NRXP Stock News - StockTitan
NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update L - GuruFocus.com
NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule - GlobeNewswire
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq th - GuruFocus.com
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics - StockTitan
HOPE Therapeutics set to acquire Florida psychiatry clinics - Investing.com
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Unde - GuruFocus.com
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024 - GuruFocus.com
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarte - GuruFocus.com
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2 - GuruFocus.com
NRx Pharmaceuticals, Inc. and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024 - Marketscreener.com
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE - GlobeNewswire
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024 - StockTitan
EF Hutton Acquisition Co. I Upgrades NRx Pharmaceuticals (NASDAQ:NRXP) to Strong-Buy - Defense World
Can Nrx combination unlock NMDA’s oomph in akathisia? - BioWorld Online
EF Hutton sets stock target on NRx Pharma, cites suicide prevention - Investing.com India
NRx started at buy by EF Hutton, cites suicide prevention focus - MSN
NRx started at buy by EF Hutton, cites suicide prevention focus (NASDAQ:NRXP) - Seeking Alpha
NRx Pharmaceuticals secures additional $5 million funding By Investing.com - Investing.com Nigeria
NRx Pharmaceuticals secures additional $5 million funding - Investing.com India
NRx Pharmaceuticals announces CEO resignation and stockholder votes - Investing.com
NRx Pharmaceuticals announces CEO resignation and stockholder votes By Investing.com - Investing.com Nigeria
NRx Pharmaceuticals Leadership Shift and Strategic Governance Decisions - Yahoo Finance
NRx Pharmaceuticals, Inc. Announces Chief Executive Officer Changes - Marketscreener.com
NRXP stock touches 52-week low at $1.33 amid market challenges - Investing.com
NRx Pharmaceuticals, Inc. announced that it has received $10 million in funding from Streeterville Capital, LLC - Marketscreener.com
NRx Pharmaceuticals Advances Towards FDA Approval with Key Stability Milestone for NRX-100 - MSN
HOPE Therapeutics and NRx Pharmaceuticals to Acquire a Premier West Coast Interventional Psychiatric Clinic - citybiz
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic - cnhinews.com
NRXP stock touches 52-week low at $1.59 amid market challenges By Investing.com - Investing.com South Africa
Verrica Pharmaceuticals Streamlines Operations to Enhance YCANTH Access - MyChesCo
NRXP stock touches 52-week low at $1.59 amid market challenges - Investing.com Australia
0.93%
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):